杨体敏;斯海波;吴元刚;曾羿;裴福兴;沈彬;

• 1:四川大学华西医院骨科

摘要(Abstract)：

[目的]研究在全膝关节置换术(TKA)后序贯应用帕瑞昔布+塞来昔布的临床疗效。[方法]纳入60例TKA患者,随机分成2组:试验组术后前3 d每12 h静脉注射帕瑞昔布40 mg,之后改为每12 h口服塞来昔布200mg至术后6周,对照组序贯使用生理盐水和相同外观的安慰剂。记录并比较两组患者术前及术后第1、2、3 d及1、2、4、6周静息及活动疼痛程度(VAS评分)、膝关节功能(HSS评分)、炎症指标值、不良反应发生率及术后2周内凝血功能指标值等。[结果]试验组术后前3 d静息VAS评分及术后各时间点活动VAS评分均显著低于对照组(P<0.05)。试验组术后1、2、4周膝关节HSS评分显著高于对照组(P<0.05),两组术后6周HSS评分差异无统计学意义。试验组术后各时间点血沉、术后1周内C反应蛋白、术后2周内IL-6、术后前3 d IL-8及TNF-α水平均低于对照组,差异有统计学意义(P<0.05)。两组患者各时间点凝血指标差异无统计学意义(P>0.05),试验组术后住院天数及术后恶心呕吐发生率均显著低于对照组(P<0.05)。[结论]TKA术后序贯应用帕瑞昔布+塞来昔布镇痛效果满意,能促进术后早期关节功能康复、减轻术后早期炎症反应、缩短术后住院周期及减少不良反应发生率。

关键词(KeyWords)： 全膝关节置换术;骨关节炎;帕瑞昔布;塞来昔布;术后疼痛

Abstract:

Keywords:

基金项目(Foundation): 国家行业科研专项项目(编号:201302007);; 四川大学华西医院学科卓越发展1.3.5工程项目

作者(Author): 杨体敏;斯海波;吴元刚;曾羿;裴福兴;沈彬;

Email:

DOI:

参考文献(References)：

• [1]Scott WW,Levy M,Rickert KL,et al.Assessment of common nonsteroidal anti-inflammatory medications by whole blood aggregometry:a clinical evaluation for the perioperative setting[J].World Neurosurg,2014,82(5):e633-638.
• [2]Robinson CM,Christie J,Malcolm-Smith N.Nonsteroidal antiinflammatory drugs,perioperative blood loss,and transfusion requirements in elective hip arthroplasty[J].J Arthroplasty,1993,8(6):607-610.
• [3]Lin J,Zhang L,Yang H.Perioperative administration of selective cyclooxygenase-2 inhibitors for postoperative pain management in patients after total knee arthroplasty[J].J Arthroplasty,2013,28(2):207-213.
• [4]Ittichaikulthol W,Prachanpanich N,Kositchaiwat C,et al.The post-operative analgesic efficacy of celecoxib compared with placebo and parecoxib after total hip or knee arthroplasty[J].J Med Assoc Thai,2010,93(8):937-942.
• [5]Vane JR,Botting RM.Mechanism of action of nonsteroidal anti-inflammatory drugs[J].Am J Med,1998,104(3a):2S-8S,21S-22S.
• [6]Mederle K,Meurer M,Castrop H,et al.Inhibition of COX-1 attenuates the formation of thromboxane A2 and ameliorates the acute decrease in glomerular filtration rate in endotoxemic mice[J].Am J Physiol Renal Physiol,2015,309(4):F332-340.
• [7]黄伟.塞来昔布在骨科围手术期超前镇痛中的作用[J].国际骨科学杂志,2010,31(6):374-375.
• [8]Oksuz E,Atalar F,Tanirverdi G,et al.Therapeutic potential of cyclooxygenase-3 inhibitors in the management of glioblastoma[J].JNeurooncol,2016,126(2):271-278.
• [9]王海兴林,陈桂浩,等.塞来昔布对全髋关节置换患者术前疼痛影响的随机双盲对照研究[J].中国矫形外科杂志,2014,22(4):315-319.
• [10]Kazerooni R,Tran MH.Evaluation of celecoxib addition to pain protocol after total hip and knee arthroplasty stratified by opioid tolerance[J].Clin J Pain,2015,31(10):903-908.
• [11]Narita M,Shimamura M,Imai S,et al.Role of interleukin-1beta and tumor necrosis factor-alpha-dependent expression of cyclooxygenase-2 m RNA in thermal hyperalgesia induced by chronic inflammation in mice[J].Neuroscience,2008,152(2):477-486.
• [12]Chen X,Bai C,Xie L,et al.Inflammatory response to orthopedic biomaterials after total hip replacement[J].J Orthop Sci,2012,17(4):407-412.
• [13]Honsawek S,Deepaisarnsakul B,Tanavalee A,et al.Relationship of serum IL-6,C-reactive protein,erythrocyte sedimentation rate,and knee skin temperature after total knee arthroplasty:a prospective study[J].Int Orthop,2011,35(1):31-35.
• [14]Miller RE,Miller RJ,Malfait AM.Osteoarthritis joint pain:the cytokine connection[J].Cytokine,2014,70(2):185-193.
• [15]Lin E,Calvano SE,Lowry SF.Inflammatory cytokines and cell response in surgery[J].Surgery,2000,127(2):117-126.
• [16]Thomas T,Robinson C,Champion D,et al.Prediction and assessment of the severity of post-operative pain and of satisfaction with management[J].Pain,1998,75(2-3):177-185.
• [17]Reuben SS,Buvenandran A,Katz B,et al.A prospective randomized trial on the role of perioperative celecoxib administration for total knee arthroplasty:improving clinical outcomes[J].Anesth Analg,2008,106(4):1258-1264.